Armistice Capital »

GeoVax Labs shares owned by Armistice Capital

Quarter-by-quarter ownership of GeoVax Labs (GOVX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in GeoVax Labs

Tip: Access up to 7 years of quarterly data

All positions including GeoVax Labs held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GeoVax Labs by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $372k 269k 1.38

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding GeoVax Labs

Armistice Capital
Geode Capital Management
Vanguard Fiduciary Trust
UBS Group
Vanguard Capital Management
BlackRock
SBI Securities
Wells Fargo & Company
Morgan Stanley
Danske Bank A/s
Caitong International Asset Management
Royal Bank of Canada
Quaker Wealth Management

View all funds holding GeoVax Labs